Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 59, Issue 2, 2005, Pages 209-214

  Wang, Jijun ^a,b   Hirayasu, Yoshio ^c   Hokama, Hiroto ^b   Tanaka, Shin ^d   Kondo, Tsuyoshi ^b   Zhang, Mingdao ^a   Xiao, Zeping ^a  

^a SHANGHAI MENTAL HEALTH CENTER   (China)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Duration of untreated psychosis (DUP); First episode schizophrenia; Neuroleptic medication; P300

Indexed keywords

BROMPERIDOL; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CATATONIA; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSION; DISEASE DURATION; DISORIENTATION; DRUG EFFECT; ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; MALE; PARIETAL LOBE; PSYCHOSIS; RATING SCALE; SCHIZOPHRENIA; SYMPTOM; TEMPORAL CORTEX; THOUGHT DISORDER;

ADULT; ANTIPSYCHOTIC AGENTS; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 17144388655     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2005.01360.x     Document Type: Article

References (19)

1. Lieberman JA, Perkins D, Belger A et al. The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiatry 2001; 50: 884-897.
2. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biol. Psychiatry 1999; 46: 899-907.
3. Hirayasu Y, Asato N, Ohta H, Hokama H, Arakaki H, Ogura C. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment. Biol. Psychiatry 1998; 43: 244-253.
4. Asato N, Hirayasu Y, Hiramatsu KI, Ohta H. ERPs changes during neuroleptic treatment in schizophrenia: A vulnerability marker in schizophrenia. Psychiatr. Neurol. Jpn. 1999; 101: 254-276 (in Japanese).
5. Coburn KL, Shillcutt SD, Tucker KA et al. P300 delay and attenuation in schizophrenia: Reversal by neuroleptic medication. Biol. Psychiatry 1998; 44: 466-474.
6. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr. Res. 2002; 54: 223-230.
7. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799-812.
8. Wang J, Hirayasu Y, Hiramatsu K, Hokama H, Miyazato H, Ogura C. Increased rate of P300 latency prolongation with age in drug-naive and first episode schizophrenia. Clin. Neurophysiol. 2003; 114: 2029-2935.
9. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: Its relation to quality of life and symptom remission in first-episode schizophrenia. Am. J. Psychiatry 2000; 157: 808-815.
10. Ford JM, White PM, Csernansky JG, Faustman WO, Roth WT, Pfefferbaum A. ERPs in schizophrenia: Effects of antipsychotic medication. Biol. Psychiatry 1994; 36: 153-170.
11. Duncan CC. Event-related brain potentials: A window on information processing in schizophrenia. Schizophr. Bull. 1988; 14: 199-203.
12. Lieberman JA, Tollefson G, Tohen M et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol. Am. J. Psychiatry 2003; 160: 1396-1404.
13. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry 1999; 156: 1342-1348.
14. McCarley RW, Salisbury DF, Hirayasu Y et al. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch. Gen. Psychiatry 2002; 59: 321-331.
15. Kasai K, Shenton ME, Salisbury DF et al. Progressive decrease of left superior temporal gyrus gray matter volume in first-episode schizophrenia. Am. J. Psychiatry 2003; 160: 156-164.
16. Kasai K, Shenton ME, Salisbury DF et al. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first episode schizophrenia: A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2003; 60: 766-775.
17. Hirayasu Y, Tanaka S, Shenton ME et al. Prefrontal gray matter volume reduction in first episode schizophrenia. Cereb. Cortex 2001; 11: 374-381.
18. Wiegand LC, Warfield SK, Levitt JJ et al. Prefrontal cortical thickness in first-episode psychosis: A magnetic resonance imaging study. Biol. Psychiatry 2004; 55: 131-140.
19. Umbricht D, Javitt D, Novak G et al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol. Psychiatry 1998; 44: 716-725.